Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
Human LOXL2 ELISA Kit for Sandwich ELISA - ABIN421170
Coral, Madhavan, Pukhraj, Angayarkanni: High glucose induced differential expression of lysyl oxidase and its isoform in ARPE-19 cells. in Current eye research 2013
Show all 3 Pubmed References
Dmloxl-1 and Dmloxl-2 are differentially expressed; active DmLOXL-1 influences gene expression and development
higher LOXL2 expression is associated with the invasiveness of pancreatic cancer cells and the low survival rate of pancreatic cancer patients
LOXL2 c.C133T is a pathogenic mutation that is responsible for a fraction of familial intracranial aneurysms.
data demonstrate that proteolytic processing is an important event that allows LOXL2-mediated crosslinking of basement membrane collagen IV (show COL4 ELISA Kits).
new LOXL2 splice variant contributes to tumor progression by novel molecular mechanisms different from LOXL2WT
LOXL2 is a potential therapeutic target against tumor progression.
Insulin (show INS ELISA Kits) resistance promotes lysyl oxidase like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
SMYD3 (show SMYD3 ELISA Kits) enhances tumorigenicity in esophageal squamous cell carcinoma by enhancing transcription of ezrin (show EZR ELISA Kits) and LOXL2, which are involved in proliferation, migration, and invasion.
Data show that lysyl oxidase-like 2 (LOXL2) is a histone modifier enzyme that removes trimethylated lysine 4 (K4) in histone H3 (show HIST3H3 ELISA Kits) (H3K4me3) through an amino-oxidase reaction.
LOXL2 was determined to promote proliferation of hepatocellular carcinoma (HCC (show FAM126A ELISA Kits)) and demonstrated to be highly expressed in HCC (show FAM126A ELISA Kits) adjacent non-tumor tissue samples compared with tumor tissue samples.
LOXL2 messenger RNA levels were increased in intrahepatic cholangiocarcinoma. These results were confirmed at a protein level, with a significantly higher LOXL2 immunostaining tumoral stroma. Univariate analysis revealed that LOXL2 expression was correlated with a poor overall survival and disease-free survival.
Findings indicate a pathophysiologic role and function for lysyl oxidase (show LOX ELISA Kits)-like protein LOXL2 (show LOXL3 ELISA Kits) in breast cancer metastasis.
Insulin (show INS ELISA Kits) resistance promotes lysyl oxidase like 2 (show LOXL3 ELISA Kits) induction and fibrosis accumulation in non-alcoholic fatty liver disease.
glomerular extracellular matrix. Altogether, we demonstrate that LOXL2 (show LOXL3 ELISA Kits) is a novel component of the molecular machinery that forms cross-linked collagen IV (show COL4 ELISA Kits) networks, which are essential for glomerular basement membrane stability and molecular ultrafiltration function.
LOX (show LOX ELISA Kits) and LOXL2 (show LOXL3 ELISA Kits) may play an important role in the pathogenesis of AMD (show AMD1 ELISA Kits). Targeting LOXL2 (show LOXL3 ELISA Kits) could have a broader efficacy than targeting LOX (show LOX ELISA Kits), by reducing angiogenesis and inflammation, as well as fibrosis.
Loss and gain of function analyses combined with in vivo studies in syngeneic breast cancer models demonstrate the participation of LOXL2 (show LOXL3 ELISA Kits) and E47 (show TCF3 ELISA Kits) in tumor growth and their requirement for lung metastasis.
Findings reveal new insight into the mechanisms of fibroblast activation, a novel function of LOXL2 (show LOXL3 ELISA Kits), and further highlight the importance of generating LOXL2 (show LOXL3 ELISA Kits)-targeted therapies for the prevention of tumor progression and metastasis.
The Snail1 (show SNAI1 ELISA Kits) transcription factor represses mouse pericentromeric transcription, acting through the H3K4 deaminase LOXL2 (show LOXL3 ELISA Kits).
The enzymatic activity of lysyl oxidas-like-2 (LOXL2 (show LOXL3 ELISA Kits)) is not required for LOXL2 (show LOXL3 ELISA Kits)-induced inhibition of keratinocyte differentiation.
This study provides the first evidence for the role of LOXL2 (show LOXL3 ELISA Kits) in regulating angiogenesis through collagen IV (show COL4 ELISA Kits) scaffolding.
LOXL2 (show LOXL3 ELISA Kits) promotes chondrocyte differentiation by mechanisms that are likely to include roles as both a regulator and an effector of chondrocyte differentiation
This gene encodes a member of the lysyl oxidase gene family. The prototypic member of the family is essential to the biogenesis of connective tissue, encoding an extracellular copper-dependent amine oxidase that catalyses the first step in the formation of crosslinks in collagens and elastin. A highly conserved amino acid sequence at the C-terminus end appears to be sufficient for amine oxidase activity, suggesting that each family member may retain this function. The N-terminus is poorly conserved and may impart additional roles in developmental regulation, senescence, tumor suppression, cell growth control, and chemotaxis to each member of the family.
, lysyl oxidase-like 2
, Lysyl oxidase-like protein 2
, lysyl oxidase homolog 2
, lysyl oxidase homolog 2-like
, lysyl oxidase related 2
, lysyl oxidase-like protein 2
, lysyl oxidase-related protein 2
, lysyl oxidase-related protein WS9-14
, Lysyl oxidase homolog 2